| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $867.8M | +27.7% |
| Cost of Revenue | $432.4M | +33.9% |
| Gross Profit | $435.4M | +22.1% |
| R&D Expense | $132.0M | +29.7% |
| SG&A Expense | $76.3M | +36.7% |
| Operating Income | $52.6M | -28.8% |
| Pre-tax Income | $54.0M | -25.6% |
| Income Tax | $13.0M | +107.9% |
| Net Income | $41.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $79.1M | +54.0% |
| Accounts Receivable | $93.8M | +10.1% |
| Inventory | $149.2M | +67.8% |
| Current Assets | $547.4M | +33.8% |
| Total Assets | $884.8M | +19.2% |
| Current Liabilities | $165.4M | +29.1% |
| Total Liabilities | $205.3M | +18.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $27.2M | -52.1% |
| Capital Expenditures | $14.1M | +34.4% |
| Investing Cash Flow | -$24.1M | +78.2% |
| Financing Cash Flow | $25.1M | +2.8% |
| Free Cash Flow | $13.1M | -71.7% |
| -82.8% |
| EPS (Basic) | $0.63 | -83.3% |
| EPS (Diluted) | $0.60 | -82.9% |
| Stockholders' Equity |
| $679.6M |
| +19.6% |